US Patent 7732148 Annexin A3 for prostate cancer diagnosis
Patent 7732148 was granted and assigned to ProteoSys AG. on June, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+196 characters)
Article
Patent abstract
A method treats urogenital and/or intestinal tract cancer and includes administering a therapeutically effective amount of at least one annexion protein, annexin of A3, to a mammal.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
André Schrattenholz0
Michael Cahill0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07732148 Annexin A3 for prostate cancer diagnosis US Patent 7732148 Annexin A3 for prostate cancer diagnosis
Infobox
Patent Number
077321480
Patent Number
77321480
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077321480
Date of Patent
June 8, 2010
0Patent Application Number
119208220
Date Filed
May 22, 2006
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07732148 Annexin A3 for prostate cancer diagnosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07732148
Date of patent
June 8, 2010
Patent application number
11920822
Date Filed
May 22, 2006
Patent primary examiner
Find more entities like US Patent 7732148 Annexin A3 for prostate cancer diagnosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
